Shanghai Medicilon Overview

  • Founded
  • 2004

Founded
  • Status
  • Public

  • Employees
  • 2,440

Employees
  • Stock Symbol
  • 688202

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $33.46

  • (As of Monday Closing)

Shanghai Medicilon General Information

Description

Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
SHG
Primary Office
  • No. 585 Chuanda Road
  • Pudong New Area
  • Shanghai, 201299
  • China
+86 021 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shanghai Medicilon Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$33.46 $34.20 $26.33 - $60.92 $2.98B 87M 1.13M $0.67

Shanghai Medicilon Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 2,694,509 4,679,378 1,434,163 499,093
Revenue 247,341 180,772 96,395 65,039
EBITDA 64,804 58,233 23,608 13,282
Net Income 57,875 43,708 18,728 9,635
Total Assets 303,713 281,384 216,555 161,262
Total Debt 22,421 6,834 7,729 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shanghai Medicilon Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shanghai Medicilon‘s full profile, request access.

Request a free trial

Shanghai Medicilon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range
Biotechnology
Shanghai, China
2,440 As of 2021
00000
0000 0000-00-00
00000000 00000

000 00

lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
0000000000000
Durham, NC
0000 As of 0000
0000
000000&0 0000

000000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse c
0000 000000000
Piscataway, NJ
0000 As of 0000
00000
0.000 0000-00-00
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Shanghai Medicilon Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
KBI BioPharma Formerly VC-backed Durham, NC 0000 0000 000000&0 0000
000000000 Formerly VC-backed Piscataway, NJ 0000 00000 000000000 00000
0000000 Private Equity-Backed Ann Arbor, MI 00000 0000000 0000
0000000 0000000000 Private Equity-Backed Newton, MA 00000 00000 000000000 00000
00000 000-000000 0 Venture Capital-Backed Beijing, China 0000000000 0
You’re viewing 5 of 23 competitors. Get the full list »

Shanghai Medicilon Executive Team (9)

Name Title Board Seat Contact Info
Chunlin Chen Ph.D Board Member & General Manager
Jinna Cai Ph.D Vice President, Business Development
Guodong Li Ph.D Vice President of CMC
Xiaodong Zhang Ph.D Vice President of Preclinical Research
Xingchu Gu Ph.D Vice President of Preclinical Research/Test Facility Manager
You’re viewing 5 of 9 executive team members. Get the full list »

Shanghai Medicilon Board Members (5)

Name Representing Role Since
Chunlin Chen Ph.D Shanghai Medicilon Board Member & General Manager 000 0000
Dawei Ma Shanghai Medicilon Board Member 000 0000
Guolin Wang Shanghai Medicilon Board Secretary 000 0000
Jinye Xu Shanghai Medicilon Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Shanghai Medicilon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shanghai Medicilon Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 0 05-Jul-2017 0000000000 00.000 Real Estate Services (B2C)
To view Shanghai Medicilon’s complete acquisitions history, request access »

Shanghai Medicilon ESG

Risk Overview

Risk Rating

Updated April, 01, 2022

31.28 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.0

Management

Management is related to actions taken to manage ESG issues

0.000

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,613

Rank

00.00

Percentile

Commercial Services

Industry

00 of 450

Rank

00.00

Percentile

Business Support Services

Subindustry

00 of 171

Rank

00.00

Percentile

To view Shanghai Medicilon’s complete esg history, request access »